Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Zhonghua Gan Zang Bing Za Zhi ; 26(11): 835-841, 2018 Nov 20.
Article in Chinese | MEDLINE | ID: mdl-30616318

ABSTRACT

Objective: To study the clinical value of transcatheter arterial chemoembolization (TACE) therapy for hepatocellular carcinoma with blood supply from right adrenal artery. Methods: An imaging and clinical data of HCC patients with blood supply from right adrenal artery were collected from 2012 to 2016 after TACE treatment in the Second Affiliated Hospital of Chongqing Medical University and the safety and therapeutic efficacy of complete embolization therapy was analyzed retrospectively. Results: Twenty hepatocellular carcinoma patients with blood supply from right adrenal artery had received 23 times treatment. All lesions had invaded and protruded from the exogenous development of liver capsule. There were 14 cases with lesions > 5 cm in diameter. Right adrenal artery was found to be involved in the blood supply of three cases of hepatocellular carcinoma during TACE treatment for the first time. In addition, the remaining 17 cases had also received TACE treatment for the second to sixth time. The superior, middle, and inferior adrenal arteries were involved in 13, 3, and 9 cases, respectively. Twenty-four right adrenal arteries (96.0%) superselectively cannulated were successfully embolized without any serious complications. The standard method for evaluating the efficacy of liver cancer in 20 solid tumors follow-up cases showed that three cases were completely relieved, nine cases were partially relieved, two cases were stable, and six cases were progressive. The effective rate of embolization with blood supply from right adrenal artery lesions was 60.0%, and the control rate of lesion development was 70.0%. Conclusion: The right adrenal artery is mainly located in the S5-S7 segments of the liver. TACE features are obvious to ascertain its safety and effectiveness in the treatment of right adrenal artery tumors.


Subject(s)
Adrenal Glands/blood supply , Carcinoma, Hepatocellular/blood supply , Carcinoma, Hepatocellular/therapy , Chemoembolization, Therapeutic/methods , Liver Neoplasms/blood supply , Liver Neoplasms/therapy , Adult , Carcinoma, Hepatocellular/blood , Humans , Liver Neoplasms/blood , Retrospective Studies , Treatment Outcome
2.
Eur J Surg Oncol ; 43(10): 1855-1861, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28756019

ABSTRACT

BACKGROUND: Recent publications have suggested that human epidermal growth factor receptor 2 (HER2)-negative breast cancers with "weak" estrogen receptor (ER)/progesterone receptor (PR) expression levels by immunohistochemical (IHC) analysis were considered as the triple-negative (TN) subtype. This study aimed to evaluate the overall survival (OS), disease-free survival rates (DFS), and disease-specific survival (DSS) based on ER and PR expression levels into one of three groups, ER and PR <1%, ER and PR 1%-20%, and ER or PR >20% by hormone therapy. METHODS: Medical records of 3353 breast cancer patients treated from 2006 to 2013 were retrospectively reviewed. Tumor characteristics, type of treatment, OS, DFS and DSS were evaluated among the three patient groups. RESULTS: Regarding OS, there were significant differences according to the received hormone therapy in the different groups: ER and PR <1% (P = 0.972), ER and PR 1%-20% (P = 0.264), and ER or PR >20% (P = 0.014). Regarding DFS and DSS, there were also significant differences in the different groups: ER and PR <1% (P = 0.611, 0.766), ER and PR 1%-20% (P = 0.847, 0.629), and ER or PR >20% (P = 0.031, 0.002). CONCLUSIONS: In HER2 negative breast cancer patient with hormone therapy, ER and PR expression level of 1%-20% has similar survival outcome to the ER and PR expression level of <1% by IHC analysis.


Subject(s)
Receptor, ErbB-2/metabolism , Receptors, Estrogen/biosynthesis , Receptors, Progesterone/biosynthesis , Triple Negative Breast Neoplasms/mortality , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/metabolism , Disease-Free Survival , Female , Follow-Up Studies , Hormone Replacement Therapy/methods , Humans , Immunohistochemistry , In Situ Hybridization, Fluorescence , Middle Aged , Retrospective Studies , Survival Rate/trends , Taiwan/epidemiology , Triple Negative Breast Neoplasms/drug therapy , Triple Negative Breast Neoplasms/metabolism , Young Adult
4.
Eur J Surg Oncol ; 34(1): 61-6, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17434711

ABSTRACT

PURPOSE: To evaluate the usefulness of transcatheter arterial embolization (TAE) followed by radiofrequency ablation (RFA) as combined treatment for unresectable hepatocellular carcinoma (HCC). PATIENTS AND METHODS: Thirty-six consecutive patients (cirrhosis, Child-Pugh class A or B) with solitary or oligonodular HCC were treated (41 lesions; mean size, 58.9 mm; range, 30-120 mm). RFA was performed after one TAE treatment. Local efficacy was evaluated with multiphasic computed tomography (CT) performed an average of two months after RFA and once during later follow-up. RESULTS: The mean follow-up period was 16 months (range, 2-45 months). Technical success (namely, complete tumor devascularization during the arterial phase) was achieved for 59% of lesions at the first CT evaluation and for 46% at the second evaluation. Among prognostic factors included in the analysis, only lesion diameter (< 50 mm versus > or = 50 mm) was statistically significant in terms of predicting local success (Fisher's exact test: 85% versus 43% at first CT, p<0.01; 70% versus 36% during follow-up, p=0.05). There were no major periprocedural complications. Kaplan-Meier analysis showed survival rates of 84% at 12 months and 57% at 24 months. CONCLUSIONS: Combined therapy--TAE then RFA--for unresectable HCC lesions in patients with cirrhosis produces a relatively high complete local response rate compared with TAE or RFA alone. Our results, considered with those from other case series, may help design prospective, randomized clinical trials to test combination therapy versus single-modality therapy in terms of risks and benefits.


Subject(s)
Carcinoma, Hepatocellular/therapy , Catheter Ablation/methods , Embolization, Therapeutic/methods , Liver Neoplasms/therapy , Adult , Aged , Aged, 80 and over , Carcinoma, Hepatocellular/diagnosis , Female , Follow-Up Studies , Humans , Kaplan-Meier Estimate , Liver Cirrhosis/pathology , Liver Neoplasms/diagnosis , Male , Middle Aged , Prognosis , Tomography, X-Ray Computed
5.
J Surg Oncol ; 95(2): 156-7, 2007 Feb 01.
Article in English | MEDLINE | ID: mdl-17262733

ABSTRACT

BACKGROUND: Totally implantable access ports (TIAP) placed by the cephalic vein cutdown technique have high failure rates. METHODS: We describe a guidewire assisted technique of the cephalic vein cutdown for TIAP placement that can be easily introduced catheter when difficulties in insertion of the catheter. The key point of the presented technique is the use of J guidewire to go beyond the stenosis and advancement of catheter through the guidewire into the superior vena cava. RESULTS: We used this technique for introducing the catheter in six patients without failure or complication. CONCLUSION: The presented technique is easy and simple. It can be used where there are difficulties in insertion of the catheter by cephalic vein cutdown method.


Subject(s)
Catheterization, Central Venous/methods , Catheters, Indwelling , Venous Cutdown , Antineoplastic Agents/administration & dosage , Catheterization, Central Venous/instrumentation , Humans , Neoplasms/drug therapy , Subclavian Vein
6.
Emerg Med J ; 23(9): e49, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16921070

ABSTRACT

Spontaneous massive haemothorax is rare. We describe a healthy 44 year old woman who experience sudden onset chest pain while sleeping. Chest radiograph revealed massive right pleural effusion. Progressive dyspnoea, cold sweating, and tachycardia developed later. A tube thoracostomy was performed immediately and massive haemothorax was noted. An emergency thoracotomy was performed because of unstable vital signs. Disruption of the right third intercostal vein with continuous bleeding was observed, and suture ligation of the vein was performed. The total blood loss was about 4000 ml. The patient recovered uneventfully, and her condition at follow up visits to the outpatient department was satisfactory.


Subject(s)
Hemothorax/etiology , Intercostal Muscles/blood supply , Vascular Diseases/complications , Adult , Chest Pain/etiology , Female , Hemothorax/diagnosis , Hemothorax/therapy , Humans , Pleural Effusion/diagnostic imaging , Pleural Effusion/etiology , Radiography , Rupture, Spontaneous/complications , Rupture, Spontaneous/diagnosis , Rupture, Spontaneous/therapy , Thoracostomy , Treatment Outcome , Vascular Diseases/diagnosis , Vascular Diseases/surgery , Veins
8.
J Nat Toxins ; 10(4): 291-7, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11695818

ABSTRACT

Transferrin (Tf) undergoes receptor-mediated transport through the blood-brain barrier in vivo. This property allows transferrin to act as a vector for drug transport to the brain. The present investigation examines both the profile of brain delivery of nerve growth factor (NGF)-transferrin conjugate, and its therapeutic effects on CNS neurodegeneration, which affect locomotion and memory. Delivery of NGF-Tf conjugate to the brain was measured and found to be 0.075% of the injected dose per gram of brain, which is 5-fold higher than that of biotin-NGF. The increased delivery using the NGF-Tf conjugate can be attributed to an increased BBB permeability surface area product, which is about 8-fold higher than that of biotin-NGF. Intravenous injection of biotin-NGF/Tf-avidin conjugate significantly increased neuronal survival in the substantia nigra of a Parkinson's disease mouse model. In addition, this conjugate also improved recognition and memory in Alzheimer's disease rat model. In summary, these results demonstrate that using transferrin as a delivery vector is effective in targeting NGF to the central nervous system (CNS), and may optimize the therapy of age-related neurodegenerative diseases.


Subject(s)
Blood-Brain Barrier , Nerve Growth Factor/pharmacology , Transferrin/pharmacology , Alzheimer Disease/drug therapy , Animals , Drug Carriers , Injections, Intravenous , Maze Learning/drug effects , Memory/drug effects , Mice , Models, Animal , Nerve Growth Factor/administration & dosage , Nerve Growth Factor/pharmacokinetics , Parkinsonian Disorders/drug therapy , Rats , Rats, Wistar , Substantia Nigra/drug effects , Transferrin/administration & dosage , Transferrin/pharmacokinetics
9.
Am J Hypertens ; 14(8 Pt 1): 743-8, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11497188

ABSTRACT

Sleep disordered breathing (SDB) and hypertension are commonly associated. In this study, we assessed how longitudinal measures of SDB predict a 24-h ambulatory blood pressure monitoring (ABPM) profile. Participants (n = 82) were recruited from a community-based urban (26% African American) sample and included family members of patients with laboratory diagnosed SDB (cases) and family members of neighborhood control subjects evaluated at baseline and at 5 years. Nearly all participants were normotensive and were not receiving therapy for SDB. During both examinations, the respiratory distress index (RDI) was assessed with overnight in-home polysomnography. Seated blood pressure (BP) was assessed at a baseline examination (t,) and after a 5-year follow-up period (t5), when 24-h ABPM also was performed. The change in RDI (t5-t1) over 5 years was significantly associated with 24-h mean systolic blood pressure (SBP) (P = .04), 24-h maximum diastolic blood pressure (DBP) (P = .03), sleep mean SBP (P = .05), sleep mean DBP (P < .05), and sleep maximum SBP (P = .02). Regression analysis revealed that average 24-h mean arterial pressure (MAP) and mean 24-h DBP were each best predicted by change in RDI, explaining 5% of the variance in these 24-h BP readings, and by current smoking status. After accounting for these variables, BP was not predicted by any of the other potential confounders (all P > .10). Mean RDI (averaged between t5 and t1) was associated with mean MAP, mean SBP, and maximal SBP measured during sleep. This study documents for the first time the association between changes in sleep apnea activity and BP and in a community-based normotensive sample. Further long-term evaluation of the effects of these findings and the long-term consequences of hypertension are needed.


Subject(s)
Blood Pressure/physiology , Sleep Apnea Syndromes/physiopathology , Adult , Blood Pressure Monitoring, Ambulatory , Cohort Studies , Female , Humans , Hypertension/epidemiology , Longitudinal Studies , Male , Middle Aged , Polysomnography , Risk Factors , Sleep Apnea Syndromes/epidemiology
10.
Water Res ; 35(4): 1038-46, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11235869

ABSTRACT

This work experimentally elucidates the effects of ultrasonic treatment on the physical, chemical, and biological characteristics of a waste-activated sludge. A critical ultrasonic power level exists above which, accompanied with the release of divalent cations from the sludge body, the floc structure effectively disintegrated, microbial level acceptably disinfected, and particulate organic compounds sufficiently transformed into soluble state. Both ultrasonic vibration and bulk temperature rise contribute to the treatment efficiency. Possible mechanisms of ultrasonic treatment are discussed.


Subject(s)
Sewage , Waste Disposal, Fluid/methods , Biodegradation, Environmental , Flocculation , Organic Chemicals/analysis , Sewage/chemistry , Sewage/microbiology , Temperature , Ultrasonics , Vibration
11.
J Nat Toxins ; 9(1): 73-83, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10701183

ABSTRACT

Recent study showed that transferrin receptors were concentrated on the plasma membrane of brain endothelia cells and mediated transcytosis of transferrin (Tf) through the blood-brain barrier (BBB). This property allows the transferrin to act as the brain drug transporter vector. The present investigation examined the pharmacokinetic behavior of nerve growth factor (NGF), which was conjugated to transferrin by the avidin/biotin technology, especially its brain-uptake efficiency. The area under the plasma concentration curve and the mean residence time were not significantly different for either bio-NGF or bio-NGF/AV-Tf. At the first hour after single intravenous injection, the BBB permeability surface area product of bio-NGF/AV-Tf was 0.77 microliter/min/g; it was about 8-fold higher than that of bio-NGF, and equal to that of AV-OX26. The delivery of bio-NGF/AV-Tf to brain was 0.075% of injected dose per gram brain, and it was 5-fold higher than that of bio-NGF, and 2-fold higher than that of AV-OX26. In summary, these studies demonstrated that the use of Tf as brain drug delivery vector was as effective in transporting biotinylated therapeutics as OX26, and avoided the disadvantages of its antigenicity.


Subject(s)
Blood-Brain Barrier , Nerve Growth Factor/pharmacokinetics , Receptors, Transferrin/physiology , Transferrin/pharmacokinetics , Animals , Area Under Curve , Avidin , Biotinylation , Cell Membrane/physiology , Drug Delivery Systems , Nerve Growth Factor/chemistry , Rats , Rats, Wistar , Transferrin/chemistry
12.
IEEE Trans Neural Netw ; 11(1): 215-21, 2000.
Article in English | MEDLINE | ID: mdl-18249753

ABSTRACT

A learning algorithm for the principal component analysis is developed based on the least-square minimization. The dual learning rate parameters are adjusted adaptively to make the proposed algorithm capable of fast convergence and high accuracy for extracting all principal components. The proposed algorithm is robust to the error accumulation existing in the sequential principal component analysis (PCA) algorithm. We show that all information needed for PCA can be completely represented by the unnormalized weight vector which is updated based only on the corresponding neuron input-output product. The updating of the normalized weight vector can be referred to as a leaky Hebb's rule. The convergence of the proposed algorithm is briefly analyzed. We also establish the relation between Oja's rule and the least squares learning rule. Finally, the simulation results are given to illustrate the effectiveness of this algorithm for PCA and tracking time-varying directions-of-arrival.

13.
J Nat Toxins ; 8(3): 359-62, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10591039

ABSTRACT

The nerve growth factor, NGF, from Chinese cobra Naja naja atra venom was isolated by gel-filtration and ion-exchange chromatography. Cobra NGF was characterized by analytical HPLC techniques as well as SDS-PAGE, and was proven to be a glycoprotein with a mol. wt. of 23 (+/- 2) kD and a pI of 9.2. The amino acid analysis and N-terminal sequencing were performed using conventional methods. Bioassays with cultured chick embryos ganglia and rat pheochromocytoma PC-12 cells revealed a promotion of fiber outgrowth, which is typical of NGF activity. Absence of enzymatic, toxicological, and teratogenic activities were shown by quality inspection. Since 1994, many clinical cases about volunteers receiving NGF treatment have been reported in mainland China. Bioactivities of NGF deal with a wide range of disciplines and technologies. In this paper we will discuss neuronal and non-neuronal effects of NGF treatment. Does the NGF cross the blood-brain barrier by transcytosis into the brain tissue? How is NGF important in wound healing, especially in peripheral nerve injury and diabetic neuritis? NGF may also be useful for male volunteers suffering from sterility, because it is possible that the sexual cells of testis can be promoted to maturity.


Subject(s)
Elapid Venoms/chemistry , Nerve Growth Factor/pharmacology , Animals , Blood-Brain Barrier , Chick Embryo , Chromatography, High Pressure Liquid , Electrophoresis, Polyacrylamide Gel , Ganglia/drug effects , Ganglia/ultrastructure , Glycoproteins/chemistry , Glycoproteins/pharmacokinetics , Glycoproteins/pharmacology , Glycoproteins/therapeutic use , Haplorhini , Humans , Infertility/drug therapy , Male , Mice , Nerve Fibers/drug effects , Nerve Fibers/physiology , Nerve Growth Factor/chemistry , Nerve Growth Factor/pharmacokinetics , Nerve Growth Factor/therapeutic use , PC12 Cells , Pain Measurement , Parkinson Disease/drug therapy , Peripheral Nervous System Diseases/drug therapy , Peripheral Nervous System Diseases/enzymology , Rats , Sciatic Nerve , Spinal Cord/enzymology
14.
Neuroscience ; 41(2-3): 797-807, 1991.
Article in English | MEDLINE | ID: mdl-1714555

ABSTRACT

Rat superior cervical ganglia infected with herpes virus suis (pseudorabies virus) display a spontaneous bursting activity of still unknown origin. Previous intracellular recordings from the ganglionic neurons combined with pharmacological studies showed that the postganglionic action potentials are induced by acetylcholine release spontaneously from the preganglionic nerve. In this study we investigated whether the acetylcholine release is caused by mechanisms which are dependent on action potentials spontaneously generated on the preganglionic nerve or by mechanisms which occur without any changes in the excitability of presynaptic fibers. Simultaneous intra- and extracellular recordings from the ganglion cells and from the preganglionic nerve, respectively, were performed 32-38 h after the inoculation of herpes virus suis (strain Aujeszky) into the anterior chamber of one eye of the rat. Tetrodotoxin, well known to prevent the generation of action potentials by blocking the fast sodium channels, completely and reversibly abolished, whereas the potassium channel blockers 4-aminopyridine and apamin, enhanced the spontaneous, bursting activity at pre- and postsynaptic levels. The nicotinic receptor antagonist hexamethonium abolished the postsynaptic discharges and reduced the preganglionic activity by 50%. Pre- and postsynaptic electrical activities were suppressed in low calcium Krebs' solution, demonstrating that extracellular calcium is required not only for acetylcholine release but also for triggering the presynaptic action potentials. It is concluded that in the infected ganglia the spontaneous acetylcholine release is due to the generation of action potentials in the preganglionic nerve. Voltage-gated sodium and calcium channels contribute to the presynaptic electrogenesis, while the latter appears to be damped by the activation of voltage- and calcium-dependent potassium channels. Possible factors as well as mechanisms inducing such an increase in excitability are discussed.


Subject(s)
Ganglia, Sympathetic/physiopathology , Ion Channels/physiology , Neurons/physiology , Pseudorabies/physiopathology , Synapses/physiology , 4-Aminopyridine/pharmacology , Action Potentials/drug effects , Animals , Atropine/pharmacology , Calcium Channel Blockers/pharmacology , Electric Stimulation , Evoked Potentials/drug effects , Ganglia, Sympathetic/physiology , Herpesvirus 1, Suid , Hexamethonium , Hexamethonium Compounds/pharmacology , Ion Channels/drug effects , Male , Neurons/drug effects , Physostigmine/pharmacology , Pirenzepine/pharmacology , Rats , Rats, Inbred Strains , Synapses/drug effects , Tetrodotoxin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...